Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis

Fig. 1

Physical and serological findings of the control, MSG, and MSG + FOS mice. a Changes in mean body weight, and at 18 weeks of (b) epididymal fat weight, c liver weight, d serum blood glucose levels, e serum insulin levels, f serum total cholesterol levels, and (g) serum adiponectin levels. *p < 0.05, **p < 0.01. FOS, fructo-oligosaccharides; MSG, monosodium glutamate

Back to article page